Advertisement

A precise and simple isodose-volume-based verification method for HDR and LDR brachytherapy plans

Published:January 10, 2023DOI:https://doi.org/10.1016/j.brachy.2022.12.007

      ABSTRACT

      PURPOSE

      The American Association of Physicists in Medicine (AAPM) code of practice for brachytherapy physics recommends performing an independent treatment time calculation. For this we implemented an easy to use isodose-based verification method for HDR (high-dose-rate) and LDR (low-dose-rate) brachytherapy plans.

      MATERIAL AND METHODS

      Dose-volume-based methods have been developed for Ir-192-based high-dose-rate (HDR) and I-125 prostate low-dose-rate (LDR) brachytherapy. They allow checking the integral dwell time or activity when the volume of a suitable isodose is known. The verification method was validated for 55 clinical HDR and 243 clinical LDR plans.

      RESULTS

      For HDR brachytherapy, the mean absolute difference between the estimated and calculated integral dwell time was 0.8% ± 1.0% (n = 30) with a single-source path and 2.7% ± 1.1% (n = 25) for multiple source paths. The corresponding value for LDR brachytherapy was 1.8% ± 2.0% (n = 243). In HDR brachytherapy, the verification method depends slightly on the plan class when considering one or more than one source paths. Good agreement between the estimated and calculated integral dwell times was obtained based on the 2 Gy isodose. Unlike HDR brachytherapy, the parameters used in the verification method for LDR brachytherapy plan verification strongly depend on the type of seed distribution. So, we recommend using an isodose at the prescribed dose for prostate HDR therapy.

      CONCLUSIONS

      Isodose-based verification methods are precise, do not presuppose dedicated tools, and are simple to implement in clinical practice.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brachytherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Bochud F, Leemann B, Linder R, Moeckli R, et al. Swiss Society for Radiobiology and Medical Physics; SSRMP recommendation on dosimetry and quality assurance in high dose rate brachytherapy with Iridium-192. SSRMP; recommendations No. 13, 908 125 36-7 (2005).

        • Rivard Mark J.
        • Coursey BM
        • DeWerd LA
        • Hanson WF
        • et al.
        Update of AAPM Task Group No. 43 report: a revised AAPM protocol for brachytherapy dose calculations.
        Med. Phys. 2004; 31: 633-674
        • Nath R.
        • Anderson L.L.
        • Meli J.A.
        • Olch A.J.
        • et al.
        Code of practice for brachytherapy physics: Report of AAPM; Radiation Therapy Committee Task Group No. 56.
        American Association of Physicists in Medicine, American Institute of Physics, New York1997https://doi.org/10.1118/1.597966
        • Takahashi Y
        • Koizumi M
        • Sumida I
        • Isohashi F
        • et al.
        The usefulness of an independent patient-specific treatment planning verification method using a benchmark plan in high-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix.
        J Radiat Res. 2012; : 936-944https://doi.org/10.1093/jrr/rrs035
        • Cohen GN
        • Amols HI
        • Zaider M
        An independent dose-to-point calculation program for the verification of high-dose-rate brachytherapy treatment planning.
        Int J Radiat Oncol Biol Phys. 2000; : 1251-1258https://doi.org/10.1016/s0360-3016(00)00725-2
        • Rogus RD
        • Smith MJ
        • Kubo HD
        An equation to QA check the total treatment time for single-catheter HDR brachytherapy.
        Int J Radiat Oncol Biol Phys. 1998; : 245-248https://doi.org/10.1016/s0360-3016(97)00487-2
        • Kang SW
        • Chung JB
        • Kim KH
        • Park JY
        • et al.
        Development of volumetric independent dose calculation system for verification of the treatment plan in image-guided adaptive brachytherapy.
        Front Oncol. 2020; 10: 609https://doi.org/10.3389/fonc.2020.00609
        • Fan J
        • Xing L
        • Yang Y
        Independent verification of brachytherapy treatment plan by using deep learning inference modeling.
        Phys Med Biol. 2021; 16 (66)https://doi.org/10.1088/1361-6560/ac067f
        • Tachibana H
        • Watanabe Y
        • Mizukami S
        • Maeyama T
        • et al.
        End-to-end delivery quality assurance of computed tomography-based high-dose-rate brachytherapy using a gel dosimeter.
        Brachytherapy. 2020; 19: 362-371https://doi.org/10.1016/j.brachy.2020.02.002
        • Das RK
        • A Bradley KA
        • Nelson IA
        • Patel R
        • et al.
        Quality assurance of treatment plans for interstitial and intracavitary high-dose-rate brachytherapy.
        Brachytherapy. 2020; 5 (PMID: 16563998): 56-60https://doi.org/10.1016/j.brachy.2005.11.002
        • Rivard MJ
        • Coursey BM
        • DeWerd LA
        • Hanson WF
        • et al.
        Update of AAPM Task Group No. 43 report: a revised AAPM protocol for brachytherapy dose calculations.
        Med. Phys. 2004; 31: 633-674https://doi.org/10.1118/1.1646040
      2. https://www.myvarian.com; “VariSeed 9.0 Reference Guide”, (2022), Publication ID: DOC VS 9.0 RG.